DrugBiological
CT-P6 clinical trials
A product of Trastuzumab; its studies count on that page too.
- studies test it
- 4
- open now
- 0
- in phase 3
- 1
- first study started
- 2010
How studies write it
Studies that test it under each name
Name
Studies by the year they started
4 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2020 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 1
- Phase 3
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
Celltrion (3) · Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia (1)
Studies
Open first, then newest update. How each study uses CT-P6 is read from its arms, and is right about nine times in ten.
Testing it · 4
- To Compare the Pharmacokinetics, Safety, and Immunogenicity of Subcutaneous CT-P6 and Herceptin in Healthy Male Subjects (Trastuzumab)CompletedPhase 1CelltrionNCT06687928Written as CT-P6 SC
- Study to Evaluate the Efficacy and Safety of Neoadjuvant Treatment Based on Dual Blockade With Pertuzumab and the Trastuzumab Biosimilar CT-P6 (Herzuma®) in Early HER2-positive Breast Cancer in Routine Clinical PracticeCompletedNot applicableFundacion para la Formacion e Investigacion Sanitarias de la Region de MurciaNCT06907082Written as Combination of pertuzumab and the trastuzumab biosimilar CT-P6 (Herzuma®) in Her2-positive breast cancer susceptible to neoadjuvant chemotherapy.
- Demonstrate Efficacy and Safety of Metastatic Breast CancerCompletedPhase 3CelltrionNCT01084876Written as CT-P6
- Evaluate Safety, Efficacy and PharmacokineticsCompletedPhase 1/2CelltrionNCT01084863Written as CT-P6